Ligand immobilization using thiol-disulphide exchange

Similar documents
Protein-peptide Interaction by Surface Plasmon Resonance Eiji Ishii, Yoko Eguchi and Ryutaro Utsumi *

BIAffinity Application Note

Performance of a fast Surface Plasmon Resonance based MAb quantification method

AC Immune SA, Lausanne, Switzerland *For correspondence:

SURFACE PLASMON RESONANCE-BASED SYSTEMS

Instruction AB

Basic Biacore Course. Introduction to SPR technology. Biacore Training

Reducing Non-Specific Binding in Surface Plasmon Resonance Experiments

The World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.

Validation of a concentration assay using Biacore C

GE Healthcare. Biacore X100. Getting Started

BIA Experimental Designs

GE Biacore T Check that the waste bottle is empty.

University of Colorado Denver, Biophysics Core Facility August 2008

Biosensing Probe for Quality Control Monitoring of the Structural Integrity of Therapeutic Antibodies

protein interaction analysis

Surface Plasmon Resonance Analysis of Antigen-Antibody Interaction Mitsuhiro Nishimura and Kazuyoshi Ikuta *

protein interaction analysis tech note 5540

GE Healthcare Life Sciences. A year of interaction with Biacore X100

ProteOn XPR36 Quantikinetics: Antibody Concentration and Detailed Kinetic Analysis in a Single Experimental Cycle

Enhance Your Protein Interaction Research with A New Level of Bench-Top Productivity

GE Healthcare Life Sciences. Biacore Assay Handbook

protein interaction analysis tech note 5367

Fast, precise, and accurate

Selection guide Biacore consumables

Ali Yaghi. Tamara Wahbeh. Mamoun Ahram

Endomorphin-1 and Endomorphin-2. These items may be or may be not in stock anymore. Please contact us, if you are interestet in purchasing.

Biacore. Concentration Analysis Handbook

Characterization of Small Molecule to Protein Binding

Assays and Strategies for Immunogenicity Assessment. Steven J Swanson, Ph.D. Executive Director, Medical Sciences Clinical Immunology, Amgen

Label-free interaction analysis in realtime using surface plasmon resonance

Protein analysis. Dr. Mamoun Ahram Summer semester, Resources This lecture Campbell and Farrell s Biochemistry, Chapters 5

Solutions to 7.02 Quiz II 10/27/05

Qualifying SPR immunogenicity assays Dr. Christian Kühne

Biacore. Sensor Surface Handbook

First&year&tutorial&in&Chemical&Biology&(amino&acids,&peptide&and&proteins)&! 1.&!

NHS-Activated Agarose (Dry Form)

phab Amine and Thiol Reactive Dyes

SUPPLEMENTARY MATERIAL

phab Amine and Thiol Reactive Dyes

Phage Antibody Selection With Reichert SPR System

Immunogenicity of Therapeutic Proteins. Steven J Swanson, Ph.D. Executive Director, Clinical Immunology

Reflected light a b. prism. flow chamber. flow chamber

Surface plasmon resonance

GE Healthcare Life Sciences. Getting the best out of your Biacore system

For the quick and efficient purification of highly specific and ultra pure antibodies

Streptavidin Mag Sepharose

Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A

HOOK Activated Agarose (Amine Reactive)

Case 7 A Storage Protein From Seeds of Brassica nigra is a Serine Protease Inhibitor

Application Note AN001

IRDye Infrared Dye Reagents

PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%)

Generic DELFIA Reagents

BIOSENSORS BLOCKS TO PROGRESS: 1. TECHNICAL PROBLEMS Low concentrations of analytes. 2. BUSINESS CONSTRAINTS Multi-analyte panels

Human IL10RB ELISA Pair Set ( CRFB4 )

蛋白質體學. Proteomics Amino acids, Peptides and Proteins 陳威戎 & 21

Contaminant bovine transferrin assay

Characterization of drug-plasma protein interactions using surface plasmon resonance

Biotin & Streptavidin-Agarose) by the NARD Institute Ltd. & MANAC Incorporated Group (

Contaminant bovine IgG assay

WesternMAX Alkaline Phosphatase Chemiluminescent Detection Kits

Biacore The high performance research system. Work with high sensitivity

Introduction to Protein Purification

Model Peptides Reveal Specificity of IV -Acetyltransferase from Saccharomyces cerevisiae*

Computational Methods for Protein Structure Prediction

M-Beads Magnetic Silica Beads Tools

Description. Amine reactive gel, for the preparation of peptides and proteins affinity support. Cat.number: UP56408A, 5ml UPR2289A, 5ml

ab Gold Conjugation Kit (40nm, 20OD)

Biacore X100. GE Healthcare Life Sciences. Biacore X100 Plus Package. Biacore X100 delivers:

Application of Biacore Technology

Convenient Purification of Monoclonal Antibodies using HiTrap rprotein A FF

Discovery of an entropically-driven small molecule streptavidin binder from nucleic acid-encoded libraries

ProteOn Sensor Chips Tips and Techniques

Case 7 A Storage Protein From Seeds of Brassica nigra is a Serine Protease Inhibitor Last modified 29 September 2005

Regeneration Scouting Kit

11 questions for a total of 120 points

A sensitive direct human telomerase activity assay Scott B Cohen & Roger R Reddel

Quantifying small numbers of antibodies with a near-universal protein-dna chimera

Contaminant human transferrin assay

Ab SpinTrap Ab Buffer Kit

Microarray Industry Products

Solutions for Your Research

Molecular Interactions Research

1. Cross-linking and cell harvesting

DNA/Protein Binding, Molecular Docking and in Vitro Anti-cancer Activity of some Thioether-Dipyrrinato Complexes

GE Healthcare. GammaBind G Sepharose

Efficient purification of the pertussis antigens toxin, filamentous haemagglutinin, and pertactin in chromatography workflows

Lecture 22: Questions from Quiz 2 and the Trypsin Digestion Experiment

MOLEBIO LAB #3: Electrophoretic Separation of Proteins

Separation of Monoclonal Antibodies Using TSKgel HPLC Columns

Short half-life of human IgG3 due to competition for FcRn-mediated

Characterization of Aptamer Binding using SensíQ SPR Platforms

Sulfhydryl Immobilization Kit for Proteins

Capto * Blue and Capto Blue (high sub)

SCIENTIFIC REPORT. regarding the implementation of the project between December December 2014

ab Oligonucleotide Conjugation Kit

ELISA. An introduction to the basic principles and assay formats. Innova Biosciences ltd All rights reserved

7.014 Solution Set 4

Supplementary Figure 1. Electron microscopy of gb-698glyco/1g2 Fab complex. a)

Transcription:

A P P L I C A T I T E 9 Ligand immobilization using thiol-disulphide exchange Abstract This Application ote describes an immobilization procedure based on thioldisulphide exchange, providing a valuable complement to the established amine coupling reaction. Thiol coupling is particularly useful for acidic ligands. The method is exemplified by immobilization of acidic peptides from the interleukin-2 receptor, the acidic carcinoembryonic antigen (CEA) and antibodies against β2-microglobulin. The last-named example provides a direct comparison of the thiol and amine coupling methods. Introduction Biacore's surface plasmon resonance (SPR) technology is a complete system for real-time biomolecular interaction analysis [1-4]. ne of the interacting components (the ligand) is immobilized on the surface of a sensor chip and the other component (the analyte) is injected in solution over the chip under continuous flow conditions. The established procedure for ligand immobilization links primary amine groups in the ligand to derivatized carboxyl groups on the sensor chip surface [5]. This Application ote describes an immobilization method based on thiol- disulphide exchange, a valuable alternative to amine coupling in many situations. Two variants of thiol-based coupling are available, depending on whether the thiol group is on the ligand or the surface matrix. For both methods, Biacore AB offers PDEA Thiol Coupling Reagent (Figure 1). Ligands can be immobilized via intrinsic thiol groups or via groups introduced by derivatization of carboxyl or amino groups (Table 1).. CH 2 CH 2 H 2 HCl Figure 1 PDEA Thiol Coupling Reagent (Product no. BR-1000-58). Method: Amine Thiol Functional groups -SH - + -H 2 + + (after modification) -CH - + (after modification) Table 1 Coupling chemistry for different functional groups and types of ligand. + recommended, (+) acceptable, - unsuitable. Biomolecules acidic ligands - + neutral ligands + (+) basic ligands + (+)

Peptide sequence pi SP-8 Ala Val Asn Gly Thr Ser Gln Phe Thr Cys 5.3 SP-9 Cys Leu Glu Thr Leu Thr Pro Asp Thr Gln Tyr Glu 2.8 Table 2. IL-2 receptor peptides used in the work described. Residues containing thiol groups are marked with bold face. Reagents HBS-EP10 mm HEPES ph 7.4, 150 mm acl, 3.4 mm EDTA, 0.05% Surfactant P20 SP-8 Peptide SP-8, 50 µg/ml in 10 mm a-formate, ph 4.0 SP-9 Peptide SP-9, 200 µg/ml in 10 mm a-citrate, ph 2.5 For detailed instructions regarding preparation of reagent solutions, see Instrument Handbook Immobilization protocol Time (s) Event Comments 0 HBS, flow 5 µl/min Start cycle 180 Mix HS + EDC 1:1 Activate surface Inject 10 µl 420 Inject 15 µl PDEA Modify surface 780 Inject 35 µl peptide Couple peptide 1320 Inject 20 µl cysteine/ Deactivate excess acl reactive groups 1620 End cycle Table 3. Protocol for immobilizing IL-2 receptor peptides on Sensor Chip CM5 by thiol coupling. R U 15000 10000 5000-1000 0 300 600 900 1200 1500 Time (s) Figure 2. Typical sensorgram showing the immobilization of IL-2 receptor peptides on Sensor Chip CM5. Serum Surface SP-8 Ra2 SP-9 Ra5 Peptide SP-8 1244 135 Peptide SP-9 44 4700 Sensor Chip CM5 Control 7 135 Table 4. Binding of rabbit antisera to immobilized IL-2 receptor peptides and to unmodified Sensor Chip CM5. Binding levels are expressed in resonance units. Modifying carboxyl groups with PDEA has the added advantage in the immobilization of acidic ligands that the isoelectric point of the ligand is increased. This favours electrostatic preconcentration of ligand on the sensor chip surface in the coupling procedure. Common ligands for which thiol coupling is appropriate include: Acidic proteins for which amine coupling is inefficient Peptides and other small ligands where the number of amine groups is limited ther biomolecules, where amine coupling is empirically found to be unsatisfactory. Immobilizing interleukin-2 receptor peptides by thiol coupling Interleukin-2 (IL-2) is a growth factor involved in amplifying the proliferative response of T-cells [6]. In the work described here, two peptides derived from the IL-2 receptor, one of which was acidic (pi<3), were were immobilized on a Sensor Chip CM5 via thiol groups in the peptides. Rabbit polyclonal antibodies were then passed over the immobilized ligand and binding was analyzed. Materials and methods IL-2 receptor peptides and rabbit sera containing antibodies against specific peptides were a gift from Biotest Pharma, Germany. ther materials were from Biacore AB. Immobilization of IL-2 receptor peptides Conditions for immobilizing the peptides via thiol groups are summarized in Table 3, and a typical sensorgram is shown in Figure 2. The amount of peptide immobilized (about 300 RU) corresponds to 250 fmole/mm 2. Antibody binding Immobilized peptides were challenged with 5 µl rabbit serum diluted 1/10 in HBS-EP buffer. Buffer flow was maintained at 5 µl/min throughout. After each cycle, the surface was regenerated with 10 µl 0.1 M HCl. o significant change in baseline signal or antibody binding capacity was observed after 10 cycles of regeneration. Results Each rabbit serum was injected over each thiol-immobilized IL-2 peptide, and over an unmodified Sensor Chip CM5 as a control. The results are summarized in Table 4. The sera bound specifically to both IL-2 peptides. Binding to the non-antigenic peptide was comparable with background binding. The immobilized peptides thus retain biologically relevant specific binding properties.

Immobilizing carcinoembryonic antigen (CEA) by thiol coupling Carcinoembryonic antigen (CEA) is an acidic embryonic cell surface marker that is also expressed in carcinomas [7]. The low isoelectric point (< 3.0) makes it difficult to immobilize CEA on Sensor Chip CM5 with amine coupling. Thiol coupling of PDEA-modified CEA is a tested, alternative approach. Materials and methods Purified CEA from human carcinoma metastases, and purified anti-cea monoclonal antibodies and all other materials were from Pharmacia Diagnostics AB. Modification of CEA with PDEA CEA (1 mg) and PDEA (5.5 mg) were dissolved in 1 ml 0.1 M MES buffer ph 5.0 and cooled on ice. 20 µl 0.4 M EDC in water were added and allowed to react on ice for 1 h. Low molecular weight reagents were removed by gel filtration on a AP-10 column (Amersham Biosciences). The degree of modification determined spectrophotometrically was 2.8. Immobilization of CEA Conditions for immobilizing the modified CEA on Sensor Chip CM5 are described in Table 5, and a typical sensorgram is shown in Figure 3. The amount of CEA immobilized (about 5000 RU) corresponds to the equivalent of 28 fmol/mm 2. Paired antibody binding Pairs of MAbs were tested for simultaneous binding to immobilized CEA by injecting 20 µl of one MAb followed by 20 µl of the second MAb. HBS flow was maintained at 5 µl/min throughout. After injection of the second MAb, the surface was regenerated with 15 µl 0.1 M HCl. o significant change in baseline signal or antibody binding capacity was observed after 16 cycles of surface regeneration. Results The ability of pairs of antibodies to bind simultaneously to antigen defines separate epitopes. Figure 4 shows the results of paired antibody experiments tests for 4 antibodies binding to thiol-coupled CEA. Three distinct epitopes were identified, consistant with published mapping data for CEA [7]. These results demonstrate that thiol-coupling of PDEA-modified ligand is a viable approach to immobilization of CEA. Ligand CEA PDEA-modified CEA, 200 µg/ml in 10 mm a-citrate ph 3.0 Biacore immobilization protocol Time (s) Event Comments 0 HBS-EP, flow 5 µl/min Start cycle 180 Mix HS + EDC 1:1 Activate surface Inject 10 µl 420 Inject 15 µl cystamine Introduce surface disulphides 780 Inject 15 µl DTE Reduce surface disulphides to thiols 960 Inject 35 µl CEA Couple CEA 1440 Inject 20 µl PDEA/aCl Deactivate excess reactive groups 1800 End cycle Table 5. Protocol for immobilizing PDEA-modified CEA on Sensor Chip CM5 by thiol coupling. R U 16250 11250 6250 1250-3750 0 300 600 900 1200 1500 1800 Time (s) Figure 3. Typical sensorgram showing the immobilization of PDEAmodified CEA on Sensor Chip CM5. Refer to Table 5 for a description of the procedure. I-38S1 II-10 II-17 II-16 I-38S1 II-10 II-17 II-16 II-10 II-16 I-38S1 II-17 Figure 4. Paired antibody binding to immobilized CEA. Left: Matrix showing mutual binding patterns. Right: Interpretation of the binding patterns as a two-dimensional surface-like map.

Comparison of amine- and thiol-coupled antibodies in a sandwich assay for β2-microglobulin Determination of the concentration of β2-microglobulin (β2µ) in serum using an immunometric method is an established Biacore application [8]. Here, the same assay is tested using a capturing antibody, immobilized by thiol coupling. Materials and methods Monoclonal anti-β2µ, the Ig fraction of polyclonal anti-β2µ and purified β2µ were from Pharmacia Diagnostics AB. SPDP was from Amersham Biosciences. ther materials were from Biacore AB. Figure 5. Standard curves for the β2µ assay using MAbs immobilized by thiol coupling (top) and amine coupling (bottom). Precision profiles from five-fold repeated analyses are included. Modification of anti-β2µ with SPDP 1 ml anti-β2µ MAb (1 mg/ml in 0.15 M acl) was mixed with 0.5 ml 0.3 M phosphate buffer ph 7.5 and 17 µl 2.5 mm SPDP in ethanol, and allowed to react for 2 h at room temperature. Low molecular weight reagents were removed by gel filtration. The degree of modification determined spectrophotometrically was 2.1. Immobilization of anti-β2µ SPDP-modified anti-β2m in 75 mm a-acetate ph 4.5 was immobilized on Sensor Chip CM5 using the conditions described for CEA (Table 5). The amount of anti-β2m immobilized (about 10,000 RU) corresponds to approximately 70 fmol/mm 2. Determination of β2µ To determine β2µ concentrations, 5 µl samples were injected over the immobilized MAb, followed by 4 µl Ig fraction of polyclonal anti-β2µ antibodies at 2.5 mg/ml in 10 mm HEPES buffer ph 7.5. Buffer flow was maintained at 5 µl/min throughout. The second antibody response reflects the concentration of β2µ in the sample. Results Figure 6. Correlation between β2µ determination in 30 serum samples using thiol-coupled SPDP-MAb and amine-coupled native MAb as first antibody. To evaluate thiol-coupled antibodies in the β2µ assay, SPDPmodified MAb was immobilized via surface thiol groups and the same unmodified MAb was immobilized via amine groups. Standard curves for 8 known concentrations of β2µ in HBS for the two methods are shown in Figure 5. The curves are practically identical, with precision better than 5% CV over the whole range. Figure 6 shows that correlation is excellent between thiol- and amine-coupled MAbs, for measurements on 30 serum samples diluted to give a β2µ concentration ranging from 100 to 1100 ng/ml. Correlation between the real-time Biacore assay and independent measurements using RIA has been shown previously. These tests show that performance of the β2µ assay using thioland amine-coupled MAbs is equivalent.

Chemistry of thiol-disulphide exchange coupling Ligand thiol coupling Surface thiol coupling CH C CH Sensor Chip CM5 Activate sensor chip surface with HS/EDC C Introduce disulphide with 40 mm cystamine ph 8.5 Introduce reactive disulphides with 80 mm PDEA, ph 8.5 H 2 H 2 Reduce disulphide to thiol with 0.1 M DTE SH SH Couple ligand at ph below isoelectric point Ligand-SH Ligand- Couple modified ligand at ph below isoelectric point SH -Ligand -Ligand Deactivate excess disulphides with 50 mm cysteine/1m acl ph4.3. Deactivate excess thiol with 20 mm PDEA/1 M acl ph 4.3. H 2 CH H 2 -Ligand -Ligand

References [1] Fägerstam, L., Techniques in Protein Chemistry II, ed. J. J. Villafranca, Academic Press, ew York, p. 65 (1991). [2] Jönsson,U. et al., Biotechniques 11, (1991). [3] Kretschmann, E. and Raether, H., Z. aturforschung, Teil A 23, 2135 (1968). [4] Liedberg, B., ylander, C. and Lundström, I., Sensors and Actuators 4, 299 (1983). [5] Johnsson, B., Löfås, S and Lindqvist, G. Analyt. Biochem. 198, 268 (1991). [6] Roitt, I, Essential Immunology, Blackwell Scientific Publications, xford, 7th ed. (1991). [7] Hammarström, S. et al., Cancer Research 49, 4852 (1989). Biacore is a registered trademark of Biacore AB. Copyright Biacore AB 2002 BR-9000-73 February 2002